93.67
前日終値:
$92.64
開ける:
$93.06
24時間の取引高:
8.30M
Relative Volume:
1.07
時価総額:
$138.54B
収益:
$16.75B
当期純損益:
$1.85B
株価収益率:
74.94
EPS:
1.25
ネットキャッシュフロー:
$2.37B
1週間 パフォーマンス:
+4.43%
1か月 パフォーマンス:
-1.94%
6か月 パフォーマンス:
+7.54%
1年 パフォーマンス:
+36.07%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BSX
Boston Scientific Corp
|
93.67 | 138.54B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
ABT
Abbott Laboratories
|
126.88 | 220.05B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
SYK
Stryker Corp
|
350.28 | 132.98B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
82.90 | 105.84B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
69.40 | 39.98B | 5.72B | 4.17B | 259.90M | 6.97 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
2024-10-18 | ダウングレード | Needham | Buy → Hold |
2024-05-30 | 開始されました | Goldman | Buy |
2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
2023-07-19 | 開始されました | Robert W. Baird | Outperform |
2023-06-30 | 開始されました | CL King | Buy |
2023-05-30 | 再開されました | Morgan Stanley | Overweight |
2023-03-29 | 開始されました | UBS | Buy |
2022-12-22 | 開始されました | Mizuho | Neutral |
2022-12-20 | 再開されました | Citigroup | Buy |
2022-10-18 | 開始されました | Barclays | Overweight |
2022-10-12 | 開始されました | Jefferies | Buy |
2022-07-06 | 開始されました | Wolfe Research | Outperform |
2022-05-27 | アップグレード | Needham | Hold → Buy |
2022-04-13 | 再開されました | Truist | Buy |
2022-03-02 | 再開されました | BofA Securities | Buy |
2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
2021-05-26 | ダウングレード | Needham | Buy → Hold |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-15 | 開始されました | Atlantic Equities | Overweight |
2020-09-17 | 開始されました | Truist | Buy |
2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2020-04-01 | アップグレード | Goldman | Neutral → Buy |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Neutral |
2020-02-06 | 再開されました | BTIG Research | Buy |
2019-12-30 | 繰り返されました | Cowen | Outperform |
2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
2019-09-05 | 再開されました | JP Morgan | Overweight |
2019-09-03 | 再開されました | Barclays | Overweight |
2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
2018-11-28 | 開始されました | UBS | Buy |
2018-10-16 | 開始されました | Barclays | Overweight |
2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
2018-09-07 | 繰り返されました | Needham | Strong Buy |
2018-09-04 | アップグレード | Jefferies | Hold → Buy |
2018-07-06 | 繰り返されました | Needham | Strong Buy |
2018-06-27 | 開始されました | Bernstein | Outperform |
2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific price target lowered to $113 from $120 at Truist - TipRanks
Truist Lowers Price Target for Boston Scientific (BSX) Ahead of Q1 Results | BSX Stock News - GuruFocus
Is Boston Scientific Gaining or Losing Market Support? - Benzinga
Boston Scientific (BSX) Is Considered a Good Investment by Brokers: Is That True? - Yahoo
Boston Scientific (BSX) Surges 6.8%: Is This an Indication of Further Gains? - Nasdaq
FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave - BioWorld MedTech
Lobbying Update: $20,000 of BOSTON SCIENTIFIC CORPORATION lobbying was just disclosed - Nasdaq
What to Expect From Boston Scientific’s Q1 2025 Earnings Report - Nasdaq
Boston Scientific (NYSE:BSX) Announces Robust Q4 Results With Increased Sales And Net Income - Yahoo Finance
Interventional Neurology Market Deep Research 2025-2032 | - openPR.com
What To Expect From Boston Scientific’s Q1 2025 Earnings Report - Barchart.com
PFA non-inferior, even superior, to cryoablation for paroxysmal AF - BioWorld MedTech
Boston Scientific Insiders Sell US$1.8m Of Stock, Possibly Signalling Caution - Yahoo Finance
Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry - Benzinga
Health Rounds: Some early breast cancers may not need surgery after chemo - MarketScreener
Boston Scientific (BSX) Stock Moves -1.55%: What You Should Know - Yahoo Finance
Tariffs on medical devices could raise healthcare costs - The Business Journals
Boston Scientific Sued Over Endoscopic Medical Device Patent - Bloomberg Law News
Boston Scientific (BSX) Faces Pressure from New Tariffs - GuruFocus
Stryker, Boston Scientific down as new tariffs impact medtech industry - Seeking Alpha
Price Over Earnings Overview: Boston Scientific - Benzinga
Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance
Is Boston Scientific (NYSE:BSX) A Risky Investment? - Yahoo Finance
Boston Scientific’s Farapulse matches Medtronic cryoablation in trial - Yahoo Finance
Boston Scientific CEO Michael Mahoney sells $16.4 million in stock By Investing.com - Investing.com South Africa
No benefit found for cerebral protection device in TAVR - BioWorld MedTech
Boston Scientific CEO Michael Mahoney sells $16.4 million in stock - Investing.com India
Boston Scientific closes Bolt Medical acquisition - MassDevice
Evercore ISI Adjusts Boston Scientific Price Target to $110 From $112, Maintains Outperform Rating - MarketScreener
Boston Scientific Co. (NYSE:BSX) Shares Purchased by Groupama Asset Managment - MarketBeat
Boston Scientific announces conference call discussing first quarter 2025 results - Quantisnow
FDA Approval Boosts Boston Scientific's (BSX) Investment in Bolt Medical - GuruFocus
FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout - Yahoo
Boston Scientific (BSX): Among the Best Healthcare Stocks to Buy According to Billionaires - Insider Monkey
Boston Scientific Corp (BSX-N) Stock Price and News - The Globe and Mail
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
FDA clears Boston Scientific Bolt IVL system - MassDevice
Boston Scientific Farapulse PFA system shows superiority in head-to-head study with Medtronic cryoablation system - MassDevice
Boston Scientific Co. (NYSE:BSX) is Homestead Advisers Corp's 8th Largest Position - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo Finance
Boston Scientific to acquire SoniVie - Today's Medical Developments
$100 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today - Benzinga
International Expansion, Product Launches Support BSX Stock - Yahoo Finance
Goldman Sachs Adjusts Price Target on Boston Scientific to $116 From $119, Maintains Buy Rating - Marketscreener.com
The Zacks Analyst Blog Highlights Tesla, The Home Depot, Boston Scientific, Frequency Electronics and Bridger Aerospace - Yahoo Finance
Top Stock Reports for Tesla, Home Depot & Boston Scientific - MSN
The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic - Yahoo Finance
Boston Scientific SVP Vance Brown sells shares worth $486,702 By Investing.com - Investing.com Australia
Market Makes A Big Shift: DoorDash, Heico, Boston Scientific In Focus - Investor's Business Daily
Boston Scientific SVP Vance Brown sells shares worth $486,702 - Investing.com India
Returns Are Gaining Momentum At Boston Scientific (NYSE:BSX) - Yahoo Finance
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):